Search results
Results from the WOW.Com Content Network
The act provides immunity to the State of California and its related entities from being sued. The law immunizes public employees from liability for “instituting or prosecuting any judicial or administrative proceeding” within the scope of their employment, “even if” the employees act “maliciously and without probable cause.” (Cal. Gov. Code, § 821.6)
Business Insider analyzed a sample of nearly 1,500 federal Eighth Amendment lawsuits — including every appeals court case with an opinion we could locate filed from 2018 to 2022 and citing the ...
In addition, any consumer could act as a representative and file a class action lawsuit against a business committing unfair competition. [15] Proposition 64 allows only private plaintiffs who have "suffered injury in fact and lost money or property as a result of such unfair competition" may file suit, [ 16 ] while "unaffected" plaintiffs now ...
The California Consumers Legal Remedies Act ("CLRA") is the name for California Civil Code §§ 1750 et seq. [1] The CLRA declares unlawful several "methods of competition and unfair or deceptive acts or practices undertaken by any person in a transaction intended to result or which results in the sale or lease of goods or services to any consumer". [2]
Many of these cases have lead to class action lawsuits and proceedings by the Federal Trade Commision (FTC), resulting in a number of settlements worth millions — or even billions — of dollars ...
The California Correctional Institution and Adventist Health did not immediately respond to requests for comment. Read more: San José to pay record settlement of $12 million to man exonerated in ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
False Claims Act/FDCA 2012 4 4 (tie) Depakote: Abbott Laboratories [8] $1,500,000,000 $800 million civil ($1.5 billion with criminal component) Off-label promotion False Claims Act/FDCA 2009 5 4 (tie) Zyprexa: Eli Lilly [9] $1,450,000,000 $800 million civil ($1.45 billion with criminal component) Off-label promotion False Claims Act/FDCA 2008 10 5